Home

Caroline M Loewy

CIK 1367451 · Chief Financial Officer · last filed 2024-06-13

Caroline M Loewy is a Chief Financial Officer who has filed 38 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for EFTRW, was dated Jun 13, 2024. Across all open-market trades the lifetime net is +$109.8K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

10

Total Filings

38

Lifetime Open-Market Net

$109.8K

Filer Profile

Reported Address
300 ELLIOTT AVE WEST
SUITE 500
SEATTLE, WA 98119-4114
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Director — $0.00 — $0 3 2024-06-13
CymaBay Therapeutics, Inc. (CBAY) Delisted Director — $32.48 — $0 11 2024-03-22
CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Director 5,828 $0.05 $292 $0 1 2024-02-16
PhaseBio Pharmaceuticals Inc (PHAS) Delisted Director — $0.07 — $0 5 2022-05-20
Aptose Biosciences Inc. (APTO) Delisted Director — $1.71 — $0 6 2022-01-20
CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted Director — $10.37 — $0 1 2021-10-12
ZOGENIX, INC. (ZGNX) Delisted Director — $26.68 — $0 2 2021-05-28
LWACU Director — $10.36 — $0 1 2021-01-14
CORT Chief Financial Officer — $112.79 — $0 1 2008-12-02
PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted CFO 29,900 — — $109.8K 5 2008-03-06

Recent Filings

38 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-06-13 eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Grant (A) — $0 EDGAR
2024-03-22 CymaBay Therapeutics, Inc. (CBAY) Delisted Disp (D) — $0 EDGAR
2024-02-21 eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Grant (A) — $0 EDGAR
2024-02-16 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Other (J) +5,828 $0 EDGAR
2024-01-26 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) — $0 EDGAR
2023-09-11 eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Grant (A) — $0 EDGAR
2023-05-19 — Exer (M) +3,750 $0
2023-01-27 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) — $0 EDGAR
2022-05-20 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Grant (A) — $0 EDGAR
2022-03-09 — Disp (D) — $0
Showing 1–10 of 38
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.